MDS - Congress of Parkinson's Disease and Movement Disorders

Oct 4-8
Seoul, Korea

Huntington's Disease

Effectiveness and Safety of Deutetrabenazine in Chinese Patients with Huntington’s Disease-associated Chorea: A Multicenter Phase 4 Study

Authors:
Yangfan Cheng, Yue Huang, Jinghong Ma, Jinhui Yin, Xiaojuan Dan, Jianye Qu, Yang Li, Ge Zhang, Kasim Tugrul Ustundag, Aviva Peyser Levin, Rinat Ribalov, Handing Xie, Roy Eshet, Mikhail Zeygarnik, Jiamin Wang, Huifang Shang

Download the poster

Patient and Caregiver Perspectives on Patient Burden of Huntington Disease Chorea and the Real World Impact of Deutetrabenazine Treatment

Authors:
Daniel Claassen, W. Alex Dalrymple, Pooja Gandhi, Diana Klakotskaia, Martijn Konings, Henry P. Moore, Karen E. Anderson

Download the poster

Real-World Evaluation of Deutetrabenazine for Huntington Disease–Associated Chorea in South
Korea: Study Design and Baseline Characteristics

Authors:
Mira Jung, Roy Eshet, Kasim Tuğrul Üstündağ, Aviva Peyser Levin

Download the poster
 

Tardive Dyskinesia

Real-World Effectiveness and Safety of Deutetrabenazine in Chinese PatientsWith Tardive Dyskinesia 

Authors:
Qijing Bo, Anning Li, Wenwen Dun, Xiaoying Zhang, Zheng Wang, Jie Li, Lili Wang, Wei Li, Na Li, Yunlong Tan, Xiaojin Xu, Jianye Qu, Yang Li, Ge Zhang, Kasim Tugrul Ustundag, Aviva Peyser Levin, Rinat Ribalov, Weixiu Luo, Roy Eshet, Mikhail Zeygarnik, Shimin Bi, Gang Wang

Download the poster
 

Tourette Syndrome

Safety and Effect of Ecopipam During the First 8 Weeks of Tourette Syndrome/Disorder Treatment: A Post Hoc Analysis

Authors:
Kinga K. Tomczak, Tamar C. Katz, John A. Flatt, George B. Karkanias, Stephen P. Wanaski, Timothy M. Cunniff, Donald L. Gilbert

Download the poster

Presence of Common Psychiatric Diagnoses Did Not Impact the Efficacy or Safety of Ecopipam in Individuals With Tourette Syndrome/Disorder

Authors:
Joseph F McGuire, John A. Flatt, George B. Karkanias, Frederick E. Munschauer, Timothy M. Cunniff, Stephen P. Wanaski, Erica Greenberg

Download the poster

Receptor Selectivity Profile and Clinical Significance of Ecopipam and Relevant Metabolites, a Potential New Treatment for Tourette Syndrome (TS)

Authors:
Stephen P. Wanaski, Virginia D. Schmith, George B. Karkanias, Timothy M. Cunniff

Download the poster